Brief: Eloxx Pharmaceuticals Provides Update On The Impact Of Novel Coronavirus On Phase 2 Clinical Trials In Cystic Fibrosis

Eloxx Pharmaceuticals

25/03/2020 13:07

March 25 (Reuters) - Eloxx Pharmaceuticals Inc  ELOX.O :
    * ELOXX PHARMACEUTICALS PROVIDES UPDATE ON THE IMPACT OF
NOVEL
CORONAVIRUS (COVID-19) ON PHASE 2 CLINICAL TRIALS IN CYSTIC
FIBROSIS
    * ELOXX PHARMACEUTICALS INC - ENROLLMENT IN PHASE 2 CYSTIC
FIBROSIS TRIALS HAS BEEN PAUSED TEMPORARILY IN RESPONSE TO
COVID-19 PANDEMIC
    * ELOXX PHARMA - COMMITTED TO COMPLETING ENROLLMENT IN PHASE
2
PROOF OF CONCEPT CLINICAL TRIAL PROGRAM & REPORTING TOP LINE
DATA AS SOON AS FEASIBLE

Source text for Eikon:  ID:nGNX4DDX37 
Further company coverage:  ELOX.O 

 ((Reuters.Briefs@thomsonreuters.com;))